Clonal Dynamics after Venetoclax-Obinutuzumab Therapy: Novel Insights from the Randomized, Phase 3 CLL14 Trial-MedSci.cn - 梅斯（MedSci）

Clonal Dynamics after Venetoclax-Obinutuzumab Therapy: Novel Insights from the Randomized, Phase 3 CLL14 Trial

Al-Sawaf, O; Zhang, C; Robrecht, S; Wilson, C; Tandon, M; Ching, T; Fink, AM; Ritgen, M; Tausch, E; Kreuzer, KA; Schary, W; Wendtner, CM; Eichhorst, B; Stilgenbauer, S; Jiang, YW; Hallek, M; Fischer, K

BLOOD, 2020; 136 ():

科室
- - 订阅+
  - 更多科室
工具
服务